anlak storytelling
All kinds
Document kinds
Loading document kinds...

Primary corpus lens for browsing and insights. Selection lives in the URL.

All formats
Orientation
Loading formats...

Landscape, portrait, square, or unknown document geometry.

Unlock
MiNK Therapeutics · pitchdeck

Mink Therapeutics | IPO Presentation Deck | 36 slides

36 pages · 5 arc beats · 2 loops

Pitchdeck Download JSON
Unlock

Mink Therapeutics | IPO Presentation Deck | 36 slides

MiNK Therapeutics · 2021-10
arc beats above · slides in the middle · loops below · scroll → 2 LOOPS
SETUP TENSION ANALYSIS EVIDENCE RESOLUTION APPENDIX
HOVER FOR DETAILS · CLICK A SLIDE FOR FULLSCREEN · STEP 2
— No image bound to this slide. Wire up imgproxy to display the rendered slide JPEG.
—

Deck intelligence map

5
coverage by narrative range · generated from this deck JSON
Narrative range 6 total
Metadata
Components
Metrics
Tools
Frameworks
Beats
Loops
Problem 1 slides 100% 1/1 slides 100% 1/1 slides · 3 hits
— 0/1 slides
100% 1/1 slides
— 0/1 slides
100% 1/1 slides 100% 1/1 slides Solution 1 slides 100% 1/1 slides 100% 1/1 slides · 3 hits
— 0/1 slides
100% 1/1 slides 100% 1/1 slides 100% 1/1 slides 100% 1/1 slides Pipeline 1 slides 100% 1/1 slides 100% 1/1 slides · 4 hits
— 0/1 slides
— 0/1 slides
100% 1/1 slides 100% 1/1 slides 100% 1/1 slides Team 1 slides 100% 1/1 slides 100% 1/1 slides · 4 hits
— 0/1 slides
— 0/1 slides
— 0/1 slides
100% 1/1 slides 100% 1/1 slides Financials 2 slides 100% 2/2 slides 100% 2/2 slides · 7 hits
— 0/2 slides
100% 2/2 slides
— 0/2 slides
100% 2/2 slides 100% 2/2 slides

Slide inventory

36
every slide · same image gating as the playbook
01
Slide 1
Includes former company name and date.front_matter
Open slide detail
02
other
Open slide detail
03
analyze_data
Open slide detail
04
transition
Open slide detail
05
The slide uses a list-based summary format to outline the company's core value propositions.summarize
Open slide detailBeat · ProblemLoop · Golden Circle
06
The slide highlights specific financial figures ($50mm investment, $800mm in transactions) as evidence of the parent company's support.other
Open slide detailLoop · Golden Circle
07
The slide uses a Venn diagram to visually represent the dual nature of iNKT cells.present_solution
Open slide detailBeat · SolutionLoop · Golden Circle
08
The slide uses a Gantt-style visualization for clinical trial phases.plan_implementation
Open slide detailBeat · PipelineLoop · Golden Circle
09
other
Open slide detailBeat · TeamLoop · Golden Circle
10
transition
Open slide detailLoop · Golden Circle
11
Includes a flow cytometry plot and a dose-response killing assay.show_traction
Open slide detailLoop · Golden Circle
12
The slide uses a contrast-pairs framework to position the company's technology against the incumbent standard of care.compare_peers
Open slide detailLoop · Golden Circle
13
transition
Open slide detailLoop · Golden Circle
14
plan_implementation
Open slide detailLoop · Golden Circle
15
The slide uses a hub-and-spoke diagram to illustrate the multi-faceted mechanism of action of iNKT cells.present_solution
Open slide detailLoop · Golden Circle
16
The right side shows a series of CT scan comparisons (pre-treatment vs. iNKT treated) illustrating tumor shrinkage.show_traction
Open slide detailLoop · Golden Circle
17
The slide uses a circular process diagram to show the therapeutic mechanism of iNKT cells.present_solution
Open slide detailLoop · Golden Circle
18
Includes a Kaplan-Meier survival curve showing efficacy of iNKT cells in bone marrow transplant models.show_traction
Open slide detailLoop · Golden Circle
19
The diagram uses a hub-and-spoke model to show how iNKT cells interact with various biological targets.present_solution
Open slide detailLoop · Golden Circle
20
The slide uses a Kaplan-Meier survival curve to demonstrate the efficacy of iNKT cells in a mouse model.establish_context
Open slide detailLoop · Golden Circle
21
transition
Open slide detailLoop · Golden Circle
22
The table uses checkmarks and crosses to visually demonstrate the superiority of iNKT cells.compare_peers
Open slide detailLoop · Golden Circle
23
The chart shows a rapid decline in blood circulation and sustained presence in bone marrow.show_traction
Open slide detailLoop · Golden Circle
24
The chart shows a clear divergence between the control group (tumor alone) and the treatment group (tumor + iNKT) starting around day 15.show_traction
Open slide detailLoop · Golden Circle
25
The chart is a dot plot showing the number of metastases across six treatment groups (A-F). Group F shows the lowest number of metastases.show_traction
Open slide detailLoop · Golden Circle
26
The slide uses a comparative structure to present two distinct technological approaches.present_solution
Open slide detailLoop · Golden Circle
27
The chart shows tumor burden over time, comparing MiNK iNKT-CAR (red) against a BCMA-CAR reference (green) and untreated control (blue).show_traction
Open slide detailLoop · Golden Circle
28
transition
Open slide detailLoop · Golden Circle
29
plan_implementation
Open slide detailLoop · Golden Circle
30
The slide uses a list-based summary format to highlight key value drivers.summarize
Open slide detailLoop · Golden Circle
31
This appears to be a closing or transition slide given the slide number 31.front_matter
Open slide detailLoop · Golden Circle
32
establish_context
Open slide detailLoop · Golden Circle
33
Uses a balance scale metaphor to represent the modulation between TH1 and TH2 immune responses.present_solution
Open slide detailLoop · Golden Circle
34
The slide highlights the strategic use of Agenus' pipeline for combination therapies.plan_implementation
Open slide detailLoop · Golden Circle
35
The slide justifies the clinical trial strategy by citing small sample sizes and surrogate endpoints.analyze_data
Open slide detailBeat · FinancialsLoop · Golden Circle
36
The slide details two specific trial arms/phases for the AGENT-797 therapy.plan_implementation
Open slide detailBeat · FinancialsLoop · Golden Circle